Gland Pharma’s subsidiary Cenexi gets 11 observations from French regulator, operations unaffected

Gland Pharma confirmed that the observations will not disrupt manufacturing operations at the Fontenay site. Shares of Gland Pharma Ltd ended at ₹1,623.70, up by ₹29.90, or 1.88%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *